世界の核医学治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5899 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、核医学治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・核医学治療薬の市場動向 ・企業の競争状況、市場シェア ・核医学治療薬の種類別市場規模と予測2016-2027（ラジウム-223、ルテチウム-177、ヨウ素-131、その他） ・核医学治療薬の用途別市場規模と予測2016-2027（甲状腺、骨転移、リンパ腫、その他） ・核医学治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・核医学治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・核医学治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・核医学治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・核医学治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Novartis、China Isotope & Radiation、Dongcheng、Q BioMed、Curium Pharmaceuticals、Jubilant DraxImage、Lantheus、Spectrum Pharmaceuticals、Progenics Pharmaceuticals、International Isotopes） ・結論

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Market Analysis and Insights: Global Nuclear Drug for Therapeutic Market
The global Nuclear Drug for Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Drug for Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Drug for Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Drug for Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Drug for Therapeutic market.

Global Nuclear Drug for Therapeutic Scope and Market Size
Nuclear Drug for Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Drug for Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nuclear Drug for Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nuclear Drug for Therapeutic Market Perspective (2016-2027)
2.2 Nuclear Drug for Therapeutic Growth Trends by Regions
2.2.1 Nuclear Drug for Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Drug for Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Drug for Therapeutic Industry Dynamic
2.3.1 Nuclear Drug for Therapeutic Market Trends
2.3.2 Nuclear Drug for Therapeutic Market Drivers
2.3.3 Nuclear Drug for Therapeutic Market Challenges
2.3.4 Nuclear Drug for Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nuclear Drug for Therapeutic Players by Revenue
3.1.1 Global Top Nuclear Drug for Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Drug for Therapeutic Revenue
3.4 Global Nuclear Drug for Therapeutic Market Concentration Ratio
3.4.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2020
3.5 Nuclear Drug for Therapeutic Key Players Head office and Area Served
3.6 Key Players Nuclear Drug for Therapeutic Product Solution and Service
3.7 Date of Enter into Nuclear Drug for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Drug for Therapeutic Breakdown Data by Type
4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027)

5 Nuclear Drug for Therapeutic Breakdown Data by Application
5.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nuclear Drug for Therapeutic Market Size (2016-2027)
6.2 North America Nuclear Drug for Therapeutic Market Size by Type
6.2.1 North America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
6.3 North America Nuclear Drug for Therapeutic Market Size by Application
6.3.1 North America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
6.4 North America Nuclear Drug for Therapeutic Market Size by Country
6.4.1 North America Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nuclear Drug for Therapeutic Market Size (2016-2027)
7.2 Europe Nuclear Drug for Therapeutic Market Size by Type
7.2.1 Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
7.3 Europe Nuclear Drug for Therapeutic Market Size by Application
7.3.1 Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
7.4 Europe Nuclear Drug for Therapeutic Market Size by Country
7.4.1 Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type
8.2.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application
8.3.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region
8.4.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nuclear Drug for Therapeutic Market Size (2016-2027)
9.2 Latin America Nuclear Drug for Therapeutic Market Size by Type
9.2.1 Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Nuclear Drug for Therapeutic Market Size by Application
9.3.1 Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Nuclear Drug for Therapeutic Market Size by Country
9.4.1 Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type
10.2.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application
10.3.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country
10.4.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Nuclear Drug for Therapeutic Introduction
11.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Nuclear Drug for Therapeutic Introduction
11.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Details
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Details
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Details
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Details
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Details
11.7.2 Jubilant DraxImage Business Overview
11.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Introduction
11.7.4 Jubilant DraxImage Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.7.5 Jubilant DraxImage Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Details
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
11.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.8.5 Lantheus Recent Development
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Details
11.9.2 Spectrum Pharmaceuticals Business Overview
11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.9.4 Spectrum Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.9.5 Spectrum Pharmaceuticals Recent Development
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Details
11.10.2 Progenics Pharmaceuticals Business Overview
11.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.10.4 Progenics Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.10.5 Progenics Pharmaceuticals Recent Development
11.11 International Isotopes
11.11.1 International Isotopes Company Details
11.11.2 International Isotopes Business Overview
11.11.3 International Isotopes Nuclear Drug for Therapeutic Introduction
11.11.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
11.11.5 International Isotopes Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Nuclear Drug for Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nuclear Drug for Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nuclear Drug for Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Nuclear Drug for Therapeutic Market Share by Regions (2016-2021)
Table 10. Global Nuclear Drug for Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Nuclear Drug for Therapeutic Market Share by Regions (2022-2027)
Table 12. Nuclear Drug for Therapeutic Market Trends
Table 13. Nuclear Drug for Therapeutic Market Drivers
Table 14. Nuclear Drug for Therapeutic Market Challenges
Table 15. Nuclear Drug for Therapeutic Market Restraints
Table 16. Global Nuclear Drug for Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Nuclear Drug for Therapeutic Market Share by Players (2016-2021)
Table 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Drug for Therapeutic as of 2020)
Table 19. Ranking of Global Top Nuclear Drug for Therapeutic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Nuclear Drug for Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nuclear Drug for Therapeutic Product Solution and Service
Table 23. Date of Enter into Nuclear Drug for Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2016-2021)
Table 27. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Nuclear Drug for Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2016-2021)
Table 31. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Nuclear Drug for Therapeutic Product
Table 66. Bayer Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Nuclear Drug for Therapeutic Product
Table 71. Novartis Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. China Isotope & Radiation Company Details
Table 74. China Isotope & Radiation Business Overview
Table 75. China Isotope & Radiation Nuclear Drug for Therapeutic Product
Table 76. China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 77. China Isotope & Radiation Recent Development
Table 78. Dongcheng Company Details
Table 79. Dongcheng Business Overview
Table 80. Dongcheng Nuclear Drug for Therapeutic Product
Table 81. Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 82. Dongcheng Recent Development
Table 83. Q BioMed Company Details
Table 84. Q BioMed Business Overview
Table 85. Q BioMed Nuclear Drug for Therapeutic Product
Table 86. Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 87. Q BioMed Recent Development
Table 88. Curium Pharmaceuticals Company Details
Table 89. Curium Pharmaceuticals Business Overview
Table 90. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product
Table 91. Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 92. Curium Pharmaceuticals Recent Development
Table 93. Jubilant DraxImage Company Details
Table 94. Jubilant DraxImage Business Overview
Table 95. Jubilant DraxImage Nuclear Drug for Therapeutic Product
Table 96. Jubilant DraxImage Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 97. Jubilant DraxImage Recent Development
Table 98. Lantheus Company Details
Table 99. Lantheus Business Overview
Table 100. Lantheus Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 101. Lantheus Recent Development
Table 102. Spectrum Pharmaceuticals Company Details
Table 103. Spectrum Pharmaceuticals Business Overview
Table 104. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product
Table 105. Spectrum Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 106. Spectrum Pharmaceuticals Recent Development
Table 107. Progenics Pharmaceuticals Company Details
Table 108. Progenics Pharmaceuticals Business Overview
Table 109. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product
Table 110. Progenics Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 111. Progenics Pharmaceuticals Recent Development
Table 112. International Isotopes Company Details
Table 113. International Isotopes Business Overview
Table 114. International Isotopes Nuclear Drug for Therapeutic Product
Table 115. International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
Table 116. International Isotopes Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Drug for Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Radium-223 Features
Figure 3. Lutetium-177 Features
Figure 4. Iodine-131 Features
Figure 5. Other Features
Figure 6. Global Nuclear Drug for Therapeutic Market Share by Application: 2020 VS 2027
Figure 7. Thyroid Case Studies
Figure 8. Bone Metastasis Case Studies
Figure 9. Lymphoma Case Studies
Figure 10. Other Case Studies
Figure 11. Nuclear Drug for Therapeutic Report Years Considered
Figure 12. Global Nuclear Drug for Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nuclear Drug for Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nuclear Drug for Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Nuclear Drug for Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Nuclear Drug for Therapeutic Market Share by Players in 2020
Figure 17. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Drug for Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Drug for Therapeutic Revenue in 2020
Figure 19. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2016-2027)
Figure 41. China Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 62. China Isotope & Radiation Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 63. Dongcheng Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 64. Q BioMed Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 65. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 66. Jubilant DraxImage Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 67. Lantheus Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 69. Progenics Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 70. International Isotopes Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---